Skip to main content
Top
Published in: Health Research Policy and Systems 1/2018

Open Access 01-12-2018 | Research

Development of rapid guidelines: 2. A qualitative study with WHO guideline developers

Authors: Ivan D. Florez, Rebecca L. Morgan, Maicon Falavigna, Sérgio C. Kowalski, Yuan Zhang, Itziar Etxeandia-Ikobaltzeta, Nancy Santesso, Wojtek Wiercioch, Holger J. Schünemann

Published in: Health Research Policy and Systems | Issue 1/2018

Login to get access

Abstract

Background

Situations such as public health emergencies and outbreaks necessitate the development and publication of high-quality recommendations within a condensed timeframe. For example, WHO has produced examples of and guidance for the development of rapid guidelines (RGs). However, more information is needed to understand the experiences and perceptions of guideline developers. This is the second of a series of three articles addressing methodological issues around RGs. This study describes the perceptions and experiences of guideline developers at WHO about RGs.

Methods

We conducted interviews consisting of open- and closed-ended questions with guideline developers at WHO. Our analysis described the definition and rationale of RGs, the differences from regular guidelines with regard to timelines from topic definition until publication, barriers to identifying the evidence and the lack of a standard methodology to develop RGs.

Results

We interviewed 10 participants, the majority of whom were comfortable with the current WHO definition of RGs. Most stated that the rationale for developing RGs should be in response to new evidence about efficacy, cost-effectiveness or safety. Respondents differed with regards to the amount of time RGs should take. While the majority of participants agreed that guidelines should be based on a systematic review, this step in the process was considered the most time and resource intensive. Challenges for developing RGs included limited personnel and financial resources as well as the lack of evidence. Facilitators, in turn, that may improve RG development include additional financial and personnel resources as well as the use of virtual meetings.

Conclusions

While our study suggests a strong need and rationale for the development of RGs, standardisation of timelines and guidance on panel composition, peer-review process, conduct of meetings and sources of permissible evidence require further research.
Appendix
Available only for authorised users
Literature
1.
go back to reference Institute of Medicine. Clinical Practice Guidelines we Can Trust. Washington, DC: National Academies Press; 2011. ​Institute of Medicine. Clinical Practice Guidelines we Can Trust. Washington, DC: National Academies Press; 2011.
2.
go back to reference Scottish Intercollegiate Guidelines Network. SIGN 50: A Guideline Developers’ Handbook. Edinburgh: Scottish Intercollegiate Guidelines Network; 2008. Scottish Intercollegiate Guidelines Network. SIGN 50: A Guideline Developers’ Handbook. Edinburgh: Scottish Intercollegiate Guidelines Network; 2008.
3.
go back to reference National Institute for Health and Care Excellence N. The Guidelines Manual. London: NICE; 2012. National Institute for Health and Care Excellence N. The Guidelines Manual. London: NICE; 2012.
4.
go back to reference World Health Organization. WHO Handbook for Guideline Development. Geneva: WHO; 2014. World Health Organization. WHO Handbook for Guideline Development. Geneva: WHO; 2014.
5.
go back to reference Oxman AD, Fretheim A, Schünemann HJ. Improving the use of research evidence in guideline development: introduction. Health Res Policy Syst. 2006;4(1):1.CrossRef Oxman AD, Fretheim A, Schünemann HJ. Improving the use of research evidence in guideline development: introduction. Health Res Policy Syst. 2006;4(1):1.CrossRef
6.
go back to reference Oxman AD, Lavis JN, Fretheim A. Use of evidence in WHO recommendations. Lancet. 2007;369(9576):1883–9.CrossRefPubMed Oxman AD, Lavis JN, Fretheim A. Use of evidence in WHO recommendations. Lancet. 2007;369(9576):1883–9.CrossRefPubMed
7.
go back to reference World Health Organization. WHO handbook for guideline development. 2nd ed. Geneva: WHO; 2012. World Health Organization. WHO handbook for guideline development. 2nd ed. Geneva: WHO; 2012.
8.
go back to reference World Health Organization. Rapid Advice: Antiretroviral Therapy for HIV Infection in Adults and Adolescents. Geneva: WHO; 2009. World Health Organization. Rapid Advice: Antiretroviral Therapy for HIV Infection in Adults and Adolescents. Geneva: WHO; 2009.
9.
go back to reference World Health Organization. Rapid Advice: Treatment of Tuberculosis in Children. Geneva: WHO; 2010. World Health Organization. Rapid Advice: Treatment of Tuberculosis in Children. Geneva: WHO; 2010.
10.
go back to reference Kowalski SC, Morgan RL, Falavigna M, et al. Development of rapid guidelines: 1. Systematic review of current practices and methods. Health Res Policy Syst. Under review Kowalski SC, Morgan RL, Falavigna M, et al. Development of rapid guidelines: 1. Systematic review of current practices and methods. Health Res Policy Syst. Under review
12.
go back to reference Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.CrossRef Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.CrossRef
13.
go back to reference Sandelowski M. What's in a name? Qualitative description revisited. Res Nurs Health. 2010;33(1):77–84.PubMed Sandelowski M. What's in a name? Qualitative description revisited. Res Nurs Health. 2010;33(1):77–84.PubMed
14.
go back to reference Sandelowski M. Focus on research methods-Whatever happened to qualitative description? Res Nurs Health. 2000;23(4):334–40.CrossRefPubMed Sandelowski M. Focus on research methods-Whatever happened to qualitative description? Res Nurs Health. 2000;23(4):334–40.CrossRefPubMed
15.
go back to reference Thayer KA, Schünemann HJ. Using GRADE to respond to health questions with different levels of urgency. Environ Int. 2016;92–93:585–9. http://dx.doi.org/10.1016/j.envint.2016.03.027CrossRefPubMed Thayer KA, Schünemann HJ. Using GRADE to respond to health questions with different levels of urgency. Environ Int. 2016;92–93:585–9. http://​dx.​doi.​org/​10.​1016/​j.​envint.​2016.​03.​027CrossRefPubMed
16.
go back to reference Watt A, Cameron A, Sturm L, et al. Rapid reviews versus full systematic reviews: an inventory of current methods and practice in health technology assessment. Int J Technol Assess Health Care. 2008;24(02):133–9.CrossRefPubMed Watt A, Cameron A, Sturm L, et al. Rapid reviews versus full systematic reviews: an inventory of current methods and practice in health technology assessment. Int J Technol Assess Health Care. 2008;24(02):133–9.CrossRefPubMed
17.
go back to reference Hailey D, Corabian P, Harstall C, et al. The use and impact of rapid health technology assessments. Int J Technol Assess Health Care. 2000;16(02):651–6.CrossRefPubMed Hailey D, Corabian P, Harstall C, et al. The use and impact of rapid health technology assessments. Int J Technol Assess Health Care. 2000;16(02):651–6.CrossRefPubMed
19.
go back to reference Khangura S, Konnyu K, Cushman R, et al. Evidence summaries: the evolution of a rapid review approach. Syst Rev. 2012;1(1):1–9.CrossRef Khangura S, Konnyu K, Cushman R, et al. Evidence summaries: the evolution of a rapid review approach. Syst Rev. 2012;1(1):1–9.CrossRef
20.
go back to reference Schünemann HJ, Moja L. Reviews: Rapid! Rapid! Rapid!… and systematic. Syst Rev. 2015;4(1):1–3.CrossRef Schünemann HJ, Moja L. Reviews: Rapid! Rapid! Rapid!… and systematic. Syst Rev. 2015;4(1):1–3.CrossRef
21.
go back to reference Fretheim A, Schünemann H, Oxman AD. Improving the use of research evidence in guideline development: 5. Group processes. Health Res Policy Syst. 2006;4:17.CrossRefPubMedPubMedCentral Fretheim A, Schünemann H, Oxman AD. Improving the use of research evidence in guideline development: 5. Group processes. Health Res Policy Syst. 2006;4:17.CrossRefPubMedPubMedCentral
22.
go back to reference Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. Can Med Assoc J. 2010;182(18):E839–E42.CrossRef Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. Can Med Assoc J. 2010;182(18):E839–E42.CrossRef
23.
go back to reference Centers for Disease Control and Prevention C. Guidelines and Recommendations: A CDC Primer. Atlanta: Office of the Associate Director for Science Centers for Disease Control and Prevention; 2012. Centers for Disease Control and Prevention C. Guidelines and Recommendations: A CDC Primer. Atlanta: Office of the Associate Director for Science Centers for Disease Control and Prevention; 2012.
Metadata
Title
Development of rapid guidelines: 2. A qualitative study with WHO guideline developers
Authors
Ivan D. Florez
Rebecca L. Morgan
Maicon Falavigna
Sérgio C. Kowalski
Yuan Zhang
Itziar Etxeandia-Ikobaltzeta
Nancy Santesso
Wojtek Wiercioch
Holger J. Schünemann
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Health Research Policy and Systems / Issue 1/2018
Electronic ISSN: 1478-4505
DOI
https://doi.org/10.1186/s12961-018-0329-6

Other articles of this Issue 1/2018

Health Research Policy and Systems 1/2018 Go to the issue